Literature DB >> 19259722

Refined genomic localization of the genetic lesion in the osteopetrosis (op) rat and exclusion of three positional and functional candidate genes, Clcn7, Atp6v0c, and Slc9a3r2.

B Perdu1, P R Odgren, L Van Wesenbeeck, K Jennes, C C Mackay, W Van Hul.   

Abstract

Osteopetrosis is a disease characterised by a generalized skeletal sclerosis resulting from a reduced osteoclast-mediated bone resorption. Several spontaneous mutations lead to osteopetrotic phenotypes in animals. Moutier et al. (1974) discovered the osteopetrosis (op) rat as a spontaneous, lethal, autosomal recessive mutant. op rats have large nonfunctioning osteoclasts and severe osteopetrosis. Dobbins et al. (2002) localized the disease-causing gene to a 1.5-cM genetic interval on rat chromosome 10, which we confirm in the present report. We also refined the genomic localization of the disease gene and provide statistical evidence for a disease-causing gene in a small region of rat chromosome 10. Three strong functional candidate genes are within the delineated region. Clcn7 was previously shown to underlie different forms of osteopetrosis, in both human and mice. ATP6v0c encodes a subunit of the vacuolar H(+)-ATPase or proton pump. Mutations in TCIRG1, another subunit of the proton pump, are known to cause a severe form of osteopetrosis. Given the critical role of proton pumping in bone resorption, the Slc9a3r2 gene, a sodium/hydrogen exchanger, was also considered as a candidate for the op mutation. RT-PCR showed that all 3 genes are expressed in osteoclasts, but sequencing found no mutations either in the coding regions or in intron splice junctions. Our ongoing mutation analysis of other genes in the candidate region will lead to the discovery of a novel osteopetrosis gene and further insights into osteoclast functioning.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19259722      PMCID: PMC2718562          DOI: 10.1007/s00223-009-9229-7

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  28 in total

1.  Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification.

Authors:  Y P Li; W Chen; Y Liang; E Li; P Stashenko
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

2.  Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human.

Authors:  Nader Chalhoub; Nadia Benachenhou; Venkatesh Rajapurohitam; Monica Pata; Mathieu Ferron; Annalisa Frattini; Anna Villa; Jean Vacher
Journal:  Nat Med       Date:  2003-03-10       Impact factor: 53.440

3.  Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.

Authors:  U Kornak; D Kasper; M R Bösl; E Kaiser; M Schweizer; A Schulz; W Friedrich; G Delling; T J Jentsch
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

4.  The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: Evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification.

Authors:  Liesbeth Van Wesenbeeck; Paul R Odgren; Carole A MacKay; Marina D'Angelo; Fayez F Safadi; Steven N Popoff; Wim Van Hul; Sandy C Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-11       Impact factor: 11.205

5.  Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis.

Authors:  U Kornak; A Schulz; W Friedrich; S Uhlhaas; B Kremens; T Voit; C Hasan; U Bode; T J Jentsch; C Kubisch
Journal:  Hum Mol Genet       Date:  2000-08-12       Impact factor: 6.150

6.  Identification of a novel mutation in the coding region of the grey-lethal gene OSTM1 in human malignant infantile osteopetrosis.

Authors:  Alfredo Ramírez; Julia Faupel; Ingrid Goebel; Anne Stiller; Susanne Beyer; Christina Stöckle; Carola Hasan; Udo Bode; Uwe Kornak; Christian Kubisch
Journal:  Hum Mutat       Date:  2004-05       Impact factor: 4.878

7.  Mutation of macrophage colony stimulating factor (Csf1) causes osteopetrosis in the tl rat.

Authors:  David E Dobbins; Raman Sood; Akira Hashiramoto; Carl T Hansen; Ronald L Wilder; Elaine F Remmers
Journal:  Biochem Biophys Res Commun       Date:  2002-06-28       Impact factor: 3.575

8.  Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations.

Authors:  Matteo M Guerrini; Cristina Sobacchi; Barbara Cassani; Mario Abinun; Sara S Kilic; Alessandra Pangrazio; Daniele Moratto; Evelina Mazzolari; Jill Clayton-Smith; Paul Orchard; Fraser P Coxon; Miep H Helfrich; Julie C Crockett; David Mellis; Ashok Vellodi; Ilhan Tezcan; Luigi D Notarangelo; Michael J Rogers; Paolo Vezzoni; Anna Villa; Annalisa Frattini
Journal:  Am J Hum Genet       Date:  2008-07       Impact factor: 11.025

9.  Localization of the mutation responsible for osteopetrosis in the op rat to a 1.5-cM genetic interval on rat chromosome 10: identification of positional candidate genes by radiation hybrid mapping.

Authors:  David E Dobbins; Bina Joe; Akira Hashiramoto; Jennifer L Salstrom; Svetlana Dracheva; Lynn Ge; Ronald L Wilder; Elaine F Remmers
Journal:  J Bone Miner Res       Date:  2002-10       Impact factor: 6.741

10.  Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report.

Authors:  G J A Driessen; E J A Gerritsen; A Fischer; A Fasth; W C J Hop; P Veys; F Porta; A Cant; C G Steward; J M Vossen; D Uckan; W Friedrich
Journal:  Bone Marrow Transplant       Date:  2003-10       Impact factor: 5.483

View more
  2 in total

1.  Overexpression of a novel osteopetrosis-related gene CCDC154 suppresses cell proliferation by inducing G2/M arrest.

Authors:  Wanqin Liao; Rongsen Zhao; Liting Lu; Rongrong Zhang; Jiawei Zou; Tao Xu; Changjie Wu; Jiajia Tang; Yuezhen Deng; Xincheng Lu
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

Review 2.  The cast of clasts: catabolism and vascular invasion during bone growth, repair, and disease by osteoclasts, chondroclasts, and septoclasts.

Authors:  Paul R Odgren; Hanna Witwicka; Pablo Reyes-Gutierrez
Journal:  Connect Tissue Res       Date:  2016-01-28       Impact factor: 3.417

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.